NU vs. PFE
Compare and contrast key facts about Nu Holdings Ltd. (NU) and Pfizer Inc. (PFE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NU or PFE.
Performance
NU vs. PFE - Performance Comparison
Returns By Period
In the year-to-date period, NU achieves a 68.79% return, which is significantly higher than PFE's -8.59% return.
NU
68.79%
-0.35%
20.58%
79.11%
N/A
N/A
PFE
-8.59%
-15.12%
-10.82%
-11.60%
-2.75%
2.42%
Fundamentals
| NU | PFE | |
|---|---|---|
| Market Cap | $75.86B | $148.42B |
| EPS | $0.31 | $0.75 |
| PE Ratio | 51.10 | 34.92 |
| Total Revenue (TTM) | $7.18B | $60.11B |
| Gross Profit (TTM) | $5.01B | $36.84B |
| EBITDA (TTM) | $1.92B | $15.48B |
Key characteristics
| NU | PFE | |
|---|---|---|
| Sharpe Ratio | 1.95 | -0.52 |
| Sortino Ratio | 2.55 | -0.61 |
| Omega Ratio | 1.32 | 0.93 |
| Calmar Ratio | 2.14 | -0.23 |
| Martin Ratio | 12.54 | -1.58 |
| Ulcer Index | 5.75% | 8.11% |
| Daily Std Dev | 36.94% | 24.50% |
| Max Drawdown | -72.07% | -54.82% |
| Current Drawdown | -11.52% | -53.63% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between NU and PFE is 0.05, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
NU vs. PFE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Nu Holdings Ltd. (NU) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NU vs. PFE - Dividend Comparison
NU has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 6.77%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NU Nu Holdings Ltd. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PFE Pfizer Inc. | 6.77% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.54% | 3.70% | 3.48% | 3.34% | 3.14% |
Drawdowns
NU vs. PFE - Drawdown Comparison
The maximum NU drawdown since its inception was -72.07%, which is greater than PFE's maximum drawdown of -54.82%. Use the drawdown chart below to compare losses from any high point for NU and PFE. For additional features, visit the drawdowns tool.
Volatility
NU vs. PFE - Volatility Comparison
Nu Holdings Ltd. (NU) has a higher volatility of 13.25% compared to Pfizer Inc. (PFE) at 6.71%. This indicates that NU's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NU vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Nu Holdings Ltd. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities